↓ Skip to main content

Cognitive Enhancement

Overview of attention for book
Attention for Chapter 10: Social cognition.
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
55 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Social cognition.
Chapter number 10
Book title
Cognitive Enhancement
Published in
Handbook of experimental pharmacology, January 2015
DOI 10.1007/978-3-319-16522-6_10
Pubmed ID
Book ISBNs
978-3-31-916521-9, 978-3-31-916522-6
Authors

Patin, Alexandra, Hurlemann, René, Alexandra Patin, René Hurlemann

Abstract

Social cognition is a major problem underlying deficiencies in interpersonal relationships in several psychiatric populations. And yet there is currently no gold standard for pharmacological treatment of psychiatric illness that directly targets these social cognitive areas. This chapter serves to illustrate some of the most innovative attempts at pharmacological modulation of social cognition in psychiatric illnesses including schizophrenia, borderline personality disorder, autism spectrum disorders, antisocial personality disorder and psychopathy, social anxiety disorder, and posttraumatic stress disorder. Pharmacological modulation includes studies administering oxytocin, ecstasy (MDMA), modafinil, methylphenidate, and D-cycloserine. Furthermore, some background on social cognition research in healthy individuals, which could be helpful in developing future treatments, is provided as well as the potential for each drug as a long-term treatment option.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Unknown 54 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 10 18%
Student > Ph. D. Student 10 18%
Researcher 6 11%
Student > Postgraduate 4 7%
Professor 3 5%
Other 8 15%
Unknown 14 25%
Readers by discipline Count As %
Psychology 19 35%
Medicine and Dentistry 6 11%
Neuroscience 6 11%
Agricultural and Biological Sciences 2 4%
Chemistry 2 4%
Other 3 5%
Unknown 17 31%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 May 2015.
All research outputs
#12,415,285
of 16,281,836 outputs
Outputs from Handbook of experimental pharmacology
#332
of 497 outputs
Outputs of similar age
#151,594
of 236,481 outputs
Outputs of similar age from Handbook of experimental pharmacology
#4
of 9 outputs
Altmetric has tracked 16,281,836 research outputs across all sources so far. This one is in the 20th percentile – i.e., 20% of other outputs scored the same or lower than it.
So far Altmetric has tracked 497 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one is in the 29th percentile – i.e., 29% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 236,481 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 5 of them.